All In MedTech

FDA Clearance Tracker · P150038-S036

Exablate Neuro, Exablate Prime, Exablate Transcranial MRgFUS, Exablate Model 4000, Exablate Neuravive

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 8, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 8, 2024

Approved

Time to decision

174 days

Received Apr 17, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150038-S036
Device name
Exablate Neuro, Exablate Prime, Exablate Transcranial MRgFUS, Exablate Model 4000, Exablate Neuravive
Applicant
Insightec
Applicant location
Tirat Carmel
Received
Apr 17, 2024
Decided
Oct 8, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150038

Device type

Device class
Class III

Every decision under product code POH

FDA's approval statement

As written in FDA's record.

approval for the Exablate Model 4000 Type 1.1 System software version 9.0.1 to be compatible with Philips 1.5 Tesla (T) and 3.0 T magnetic resonance imaging (MRI) scanners, and the hardware and labeling were modified accordingly as a result of this proposed change. In addition, the P150038/S036 application proposed the following changes to the subject device:• Expanded tractography support, to allow the display of overlapping anatomical structures.• Added baseline thermometry averaging (compared to approved baseline calculation using the last “cold phase” image), for enhanced sound-to-noise ratio (SNR), within approved specifications.• Added a visual indication of auto-calibration process bar and tracking planning scan acquisition.• Enhanced cavitation monitoring mechanism requirements, to further improve the robustness of the monitoring to sporadic noises and reduce false cavitation alerts.• Added additional thermometry protocols for GE and Siemens MRI scanners as additional options for users.

Source documents

Other decisions for Insightec

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.